- Article
- Published:
IL-28, IL-29 and their class II cytokine receptor IL-28R
- Paul Sheppard1 na1,
- Wayne Kindsvogel1 na1,
- Wenfeng Xu1 na1,
- Katherine Henderson1,
- Stacy Schlutsmeyer1,
- Theodore E. Whitmore1,
- Rolf Kuestner1,
- Ursula Garrigues1,
- Carl Birks1,
- Jenny Roraback1,
- Craig Ostrander1,
- Dennis Dong1,
- Jinu Shin1,
- Scott Presnell1,
- Brian Fox1,
- Betty Haldeman1,
- Emily Cooper1,
- David Taft1,
- Teresa Gilbert1,
- Francis J. Grant1,
- Monica Tackett1,
- William Krivan1,
- Gary McKnight1,
- Chris Clegg1,
- Don Foster1 &
- …
- Kevin M. Klucher1
Nature Immunologyvolume 4, pages63–68 (2003)Cite this article
8196Accesses
1399Citations
22Altmetric
Abstract
Cytokines play a critical role in modulating the innate and adaptive immune systems. Here, we have identified from the human genomic sequence a family of three cytokines, designated interleukin 28A (IL-28A), IL-28B and IL-29, that are distantly related to type I interferons (IFNs) and the IL-10 family. We found that like type I IFNs, IL-28 and IL-29 were induced by viral infection and showed antiviral activity. However, IL-28 and IL-29 interacted with a heterodimeric class II cytokine receptor that consisted of IL-10 receptor β (IL-10Rβ) and an orphan class II receptor chain, designated IL-28Rα. This newly described cytokine family may serve as an alternative to type I IFNs in providing immunity to viral infection.
This is a preview of subscription content,access via your institution
Access options
Subscription info for Japanese customers
We have a dedicated website for our Japanese customers. Please go tonatureasia.com to subscribe to this journal.
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
¥ 4,980
Prices may be subject to local taxes which are calculated during checkout







Similar content being viewed by others
References
Pestka, S., Langer, J.A., Zoon, K.C. & Samuel, C.E. Interferons and their actions.Annu. Rev. Biochem.56, 727–777 (1987).
Moore, K.W., de Waal Malefyt, R., Coffman, R.L. & O'Garra, A. Interleukin-10 and the interleukin-10 receptor.Annu. Rev. Immunol.19, 683–765 (2001).
Kotenko, S.V. The family of IL-10-related cytokines and their receptors: related, but to what extent?Cytok. Growth Factor Rev.13, 223–240 (2002).
Biron, C.A. Role of early cytokines, including alpha and beta interferons (IFN-α/β), in innate and adaptive immune responses to viral infections.Semin. Immunol.10, 383–390 (1998).
Fellous, M. et al. Interferon-dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells.Proc. Natl. Acad. Sci. USA79, 3082–3086 (1982).
Marrack, P., Kappler, J. & Mitchell, T. Type I interferons keep activated T cells alive.J. Exp. Med.189, 521–530 (1999).
Buelens, C. et al. Interleukin-3 and interferon β cooperate to induce differentiation of monocytes into dendritic cells with potent helper T-cell stimulatory properties.Blood99, 993–998 (2002).
Oritani, K. et al. Limitin: An interferon-like cytokine that preferentially influences B-lymphocyte precursors.Nat. Med.6, 659–666 (2000).
LaFleur, D.W. et al. Interferon-κ, a novel type I interferon expressed in human keratinocytes.J. Biol. Chem.276, 39765–39771 (2001).
Novick, D., Cohen, B. & Rubinstein, M. The human interferon α/β receptor: characterization and molecular cloning.Cell77, 391–400 (1994).
Uze, G., Lutfalla, G. & Gresser, I. Genetic transfer of a functional human interferon α receptor into mouse cells: cloning and expression of its cDNA.Cell60, 225–234. (1990).
Stark, G.R., Kerr, I.M., Williams, B.R., Silverman, R.H. & Schreiber, R.D. How cells respond to interferons.Annu. Rev. Biochem.67, 227–264 (1998).
Dumoutier, L., Van Roost, E., Colau, D. & Renauld, J.C. Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor.Proc. Natl. Acad. Sci. USA97, 10144–10149 (2000).
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C.G. & de Vries, J.E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.J. Exp. Med.174, 1209–1220 (1991).
Fiorentino, D.F., Zlotnik, A., Mosmann, T.R., Howard, M. & O'Garra, A. IL-10 inhibits cytokine production by activated macrophages.J. Immunol.147, 3815–3822 (1991).
Kotenko, S.V. et al. Identification and functional characterization of a second chain of the interleukin-10 receptor complex.EMBO J.16, 5894–5903 (1997).
Xie, M.H. et al. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R.J. Biol. Chem.275, 31335–31339 (2000).
Kotenko, S.V. et al. Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rβ) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes.J. Biol. Chem.276, 2725–2732 (2001).
Liu, Y., Wei, S.H., Ho, A.S., de Waal Malefyt, R. & Moore, K.W. Expression cloning and characterization of a human IL-10 receptor.J. Immunol.152, 1821–1829 (1994).
Xu, W. et al. A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist.Proc. Natl. Acad. Sci. USA98, 9511–9516 (2001).
Weber-Nordt, R.M. et al. Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain.J. Biol. Chem.271, 27954–27961 (1996).
Hubbard, T. et al. The Ensembl genome database project.Nucleic Acids Res.30, 38–41 (2002).
Altschul, S.F., Gish, W., Miller, W., Myers, E.W. & Lipman, D.J. Basic local alignment search tool.J. Mol. Biol.215, 403–410 (1990).
Raj, N.B. & Pitha, P.M. Two levels of regulation of β-interferon gene expression in human cells.Proc. Natl. Acad. Sci. USA80, 3923–3927 (1983).
Bazan, J.F. Structural design and molecular evolution of a cytokine receptor superfamily.Proc. Natl. Acad. Sci. USA87, 6934–6938 (1990).
Dondi, E. et al. Down-modulation of type 1 interferon responses by receptor cross-competition for a shared Jak kinase.J. Biol. Chem.276, 47004–47012 (2001).
Gutterman, J.U. Cytokine therapeutics: lessons from interferon alpha.Proc. Natl. Acad. Sci. USA91, 1198–1205 (1994).
Dusheiko, G. Side effects of α interferon in chronic hepatitis C.Hepatology26 (Suppl.) 112–121 (1997).
Burge, C. & Karlin, S. Prediction of complete gene structures in human genomic DNA.J. Mol. Biol.268, 78–94 (1997).
von Heijne, G., Marrack, P., Kappler, J. & Mitchell, T. Patterns of amino acids near signal-sequence cleavage sites.Eur. J. Biochem.133, 17–21 (1983).
Blumberg, H. et al. Interleukin 20: discovery, receptor identification, and role in epidermal function.Cell104, 9–19 (2001).
Zdanov, A. et al. Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon γ.Structure3, 591–601 (1995).
Radhakrishnan, R. et al. Zinc mediated dimer of human interferon-α2 revealed by X-ray crystallography.Structure4, 1453–1463 (1996).
Familletti, P.C., Rubinstein, S. & Pestka, S. A convenient and rapid cytopathic effect inhibition assay for interferon.Meth. Enzymol.78, 387–394 (1981).
Berg, K., Hansen, M.B. & Nielsen, S.E. A new sensitive bioassay for precise quantification of interferon activity as measured via the mitochondrial dehydrogenase function in cells (MTT-method).Apmis98, 156–162 (1990).
Acknowledgements
We thank P. O'Hara, R. Adams and D. Sawislak for project advice.
Author information
Paul Sheppard, Wayne Kindsvogel and Wenfeng Xu: These authors contributed equally to this work.
Authors and Affiliations
ZymoGenetics, Inc., 1201 Eastlake Avenue E., Seattle, 98102, WA, USA
Paul Sheppard, Wayne Kindsvogel, Wenfeng Xu, Katherine Henderson, Stacy Schlutsmeyer, Theodore E. Whitmore, Rolf Kuestner, Ursula Garrigues, Carl Birks, Jenny Roraback, Craig Ostrander, Dennis Dong, Jinu Shin, Scott Presnell, Brian Fox, Betty Haldeman, Emily Cooper, David Taft, Teresa Gilbert, Francis J. Grant, Monica Tackett, William Krivan, Gary McKnight, Chris Clegg, Don Foster & Kevin M. Klucher
- Paul Sheppard
Search author on:PubMed Google Scholar
- Wayne Kindsvogel
Search author on:PubMed Google Scholar
- Wenfeng Xu
Search author on:PubMed Google Scholar
- Katherine Henderson
Search author on:PubMed Google Scholar
- Stacy Schlutsmeyer
Search author on:PubMed Google Scholar
- Theodore E. Whitmore
Search author on:PubMed Google Scholar
- Rolf Kuestner
Search author on:PubMed Google Scholar
- Ursula Garrigues
Search author on:PubMed Google Scholar
- Carl Birks
Search author on:PubMed Google Scholar
- Jenny Roraback
Search author on:PubMed Google Scholar
- Craig Ostrander
Search author on:PubMed Google Scholar
- Dennis Dong
Search author on:PubMed Google Scholar
- Jinu Shin
Search author on:PubMed Google Scholar
- Scott Presnell
Search author on:PubMed Google Scholar
- Brian Fox
Search author on:PubMed Google Scholar
- Betty Haldeman
Search author on:PubMed Google Scholar
- Emily Cooper
Search author on:PubMed Google Scholar
- David Taft
Search author on:PubMed Google Scholar
- Teresa Gilbert
Search author on:PubMed Google Scholar
- Francis J. Grant
Search author on:PubMed Google Scholar
- Monica Tackett
Search author on:PubMed Google Scholar
- William Krivan
Search author on:PubMed Google Scholar
- Gary McKnight
Search author on:PubMed Google Scholar
- Chris Clegg
Search author on:PubMed Google Scholar
- Don Foster
Search author on:PubMed Google Scholar
- Kevin M. Klucher
Search author on:PubMed Google Scholar
Corresponding author
Correspondence toKevin M. Klucher.
Ethics declarations
Competing interests
All the authors of the article are employees of ZymoGenetics, Inc. and as such receive salaries and shares of stock in ZymoGenetics.
Rights and permissions
About this article
Cite this article
Sheppard, P., Kindsvogel, W., Xu, W.et al. IL-28, IL-29 and their class II cytokine receptor IL-28R.Nat Immunol4, 63–68 (2003). https://doi.org/10.1038/ni873
Received:
Accepted:
Published:
Issue date:
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
This article is cited by
Heterologous Expression of Human IFNγ and Anti-IL17 Antibody in Leishmania tarentolae Promastigote
- Arian Karimi Rouzbahani
- Seyedeh-Zeinab Hosseini
- Farnaz Kheirandish
Acta Parasitologica (2024)
Portraying the dark side of endogenous IFN-λ for promoting cancer progression and immunoevasion in pan-cancer
- Zhen Zhen Wang
- Xiao Ling Wen
- Hong Jiu Wang
Journal of Translational Medicine (2023)
Interleukin-22 facilitates the interferon-λ-mediated production of tripartite motif protein 25 to inhibit replication of duck viral hepatitis A virus type 1
- Hao An
- Yumei Liu
- Junhao Chen
Veterinary Research (2023)
Interferone als Schlüsselfaktoren für die Pathogenese, Diagnostik und Therapie
- Claas Hinze
- Helmut Wittkowski
- Dirk Föll
Monatsschrift Kinderheilkunde (2023)
Fulminant Viral Hepatitis in Two Siblings with Inherited IL-10RB Deficiency
- Cecilia B. Korol
- Serkan Belkaya
- Emmanuelle Jouanguy
Journal of Clinical Immunology (2023)


